Hello, everyone. How was your weekend? We apologize for the delay this morning but the Pharmalot corporate campus was without juice, so we have had to switch to our Red Alert mode. We trust you understand. To cope, we are downing unusually large cups of stimulation. Meanwhile, here are some tidbits. And the usual flow of interesting items will soon appear. Have a great day...
Bayer's Xarelto Bloodthinner Matched Warfarin In Safety Study (Bloomberg News)
FDA Rejects J&J's Simponi For Additional Use (Associated Press)
Prescription Drug Prices To Plunge As Patents Expire (Associated Press)
Medicis CEO In The Spotlight After Deaths At His Mansion (Los Angeles Times)
Express Scripts Deal With Medco Could Pressure Pharma (Dow Jones)
Lupin And Medicis Sign R&D Agreement (The Business Standard)
Vietnam To Test Glaxo Antibiotic For Platisicizer (Thanh Nien News)
Canadian Intervention In Rx Market Does Not Lower Prices: Study (Pharma Times)
Drugmakers May Delay Listings On Australian Benefits Plan (Sydney Morning Herald)
India's CDSCO Issues New Guidance For Clinical Trials (Outsourcing Pharma)
India's Pharmaceutical Advisory Forum To Be Revamped (PharmaBiz)
EDITOR'S NOTE: Please check this post for updates throughout the morning
light switch pic thx to krossbow on flickr